Cargando…

Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma

In the last 10 years, major advances have been made in the diagnosis and development of selective therapies for several blood cancers, including B-cell non-Hodgkin lymphoma (B-NHL), a heterogeneous group of malignancies arising from the mature B lymphocyte compartment. However, most of these entitie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ribeiro, Marcelo L., Reyes-Garau, Diana, Armengol, Marc, Fernández-Serrano, Miranda, Roué, Gaël
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807552/ https://www.ncbi.nlm.nih.gov/pubmed/31681423 http://dx.doi.org/10.3389/fgene.2019.00986

Ejemplares similares

Pharmacological Targeting of BET Bromodomain Proteins in Acute Myeloid Leukemia and Malignant Lymphomas: From Molecular Characterization to Clinical Applications
por: Reyes-Garau, Diana, et al.
Publicado: (2019)

Immune-Checkpoint Inhibitors in B-Cell Lymphoma
por: Armengol, Marc, et al.
Publicado: (2021)

Epigenetic targets in B- and T-cell lymphomas: latest developments
por: Ribeiro, Marcelo Lima, et al.
Publicado: (2023)

Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non–Hodgkin Lymphoma
por: Ribeiro, Marcelo Lima, et al.
Publicado: (2021)

G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapy
por: Ribeiro, Marcelo Lima, et al.
Publicado: (2023)

Ikaros as a downstream mediator of BCR blockade therapy in B-cell non-Hodgkin lymphoma
por: Ribeiro, Marcelo Lima, et al.
Publicado: (2022)

Editorial: B Cell Non-Hodgkin’s Lymphoma & Tumor Microenvironment Crosstalk: An Epigenetic Matter?
por: Denizot, Y, et al.
Publicado: (2022)

Epigenetic Regulation of miR-92a and TET2 and Their Association in Non-Hodgkin Lymphoma
por: Elliott, Esther K., et al.
Publicado: (2021)

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas
por: Witte, Hanno Maximilian, et al.
Publicado: (2023)

Recent advances in the management of Hodgkin lymphoma
por: Villasboas, Jose C., et al.
Publicado: (2016)

Recent advances in epigenetic anticancer therapeutics and future perspectives
por: Ren, Liwen, et al.
Publicado: (2023)

Recent Advances in Genetic and Epigenetic Modulation of Animal Exposure to High Temperature
por: Wu, Jiong, et al.
Publicado: (2020)

Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation
por: Dlouhy, Ivan, et al.
Publicado: (2021)

Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation
por: Dlouhy, Ivan, et al.
Publicado: (2022)

Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma
por: Santos, Juliana Carvalho, et al.
Publicado: (2022)

DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin’s Lymphomas
por: Yim, Rita Lok-Hay, et al.
Publicado: (2012)

Systematic Analysis of Competing Endogenous RNA Networks in Diffuse Large B-Cell Lymphoma and Hodgkin’s Lymphoma
por: Kang, Juanjuan, et al.
Publicado: (2020)

Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma
por: Eberth, Sonja, et al.
Publicado: (2010)

Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2018)

Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma
por: Feugier, Pierre, et al.
Publicado: (2019)

Advances in Epigenetic Cancer Therapeutics
por: Hillyar, Christopher, et al.
Publicado: (2020)

Management of Drug Resistance in Mantle Cell Lymphoma
por: Roué, Gaël, et al.
Publicado: (2020)

Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2019)

Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells
por: Cai, Huarui, et al.
Publicado: (2022)

Histone Modifications and Their Targeting in Lymphoid Malignancies
por: Fernández-Serrano, Miranda, et al.
Publicado: (2021)

Current advances in Hodgkin’s lymphoma
por: Vadakara, Joseph, et al.
Publicado: (2019)

Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas
por: Profitós-Pelejà, Núria, et al.
Publicado: (2022)

Controversies and Recent Advances in Hematopoietic Cell Transplantation for Follicular Non-Hodgkin Lymphoma
por: Kanate, Abraham S., et al.
Publicado: (2012)

Recent advances in immunotherapy for B-cell non-Hodgkin lymphoma and multiple myeloma
por: Chavez, Julio C., et al.
Publicado: (2022)

Non-Hodgkin’s Lymphoma and Colorectal Carcinoma: Metachronous Occurrence in a Patient With Underlying DNA Mismatch Repair Syndrome
por: Shaukat, Zunaira, et al.
Publicado: (2020)

Recent Bioinformatic Progress to Identify Epigenetic Changes Associated to Transposable Elements
por: Lerat, Emmanuelle
Publicado: (2022)

MicroRNA signature in classical Hodgkin lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2021)

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
por: Martinez, Victor G., et al.
Publicado: (2019)

Editorial: Development of Healthy and Nutritious Cereals: Recent Insights on Molecular Advances in Breeding
por: Swamy, B. P. Mallikarjuna, et al.
Publicado: (2021)

Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies
por: Banerjee, Diponkar
Publicado: (2011)

Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment
por: Diamantidis, Michael D, et al.
Publicado: (2021)

Hypotension Associated with Advanced Hodgkin Lymphoma
por: Mangla, Ankit, et al.
Publicado: (2014)

Managing advanced stage Hodgkin lymphoma
por: Saikia, TK
Publicado: (2015)

Editorial: Advances in the treatment of Hodgkin lymphoma
por: Mei, Matthew, et al.
Publicado: (2023)

Advances in the treatment of Hodgkin's lymphoma (Review)
por: Che, Yuxuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uqvgupb52mha2lu578kbdul5af